Screener
Balchem BCPC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Balchem’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000009326-26-000018
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from stock options exercised | 6,727 | 1,668 |
| Dividends paid | (30,769) | (28,263) |
| Repurchases of common stock | (15,690) | (5,325) |
| Net cash used in financing activities | (34,783) | (31,969) |
| Effect of exchange rate changes on cash | (683) | 1,810 |
| (Decrease) increase in cash and cash equivalents | (1,697) | 386 |
| Cash and cash equivalents beginning of period | 74,570 | 49,515 |
| Cash and cash equivalents end of period | $72,873 | $49,901 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Balchem's cash & equivalents?
- Balchem (BCPC) reported cash & equivalents of $72.87M in Q1 2026.
- How has Balchem's cash & equivalents changed year-over-year?
- Balchem's cash & equivalents increased by 46.0% year-over-year, from $49.9M to $72.87M.
- What is the long-term trend for Balchem's cash & equivalents?
- Over 5 years (2020 to 2025), Balchem's cash & equivalents has grown at a -2.5% compound annual growth rate (CAGR), from $84.57M to $74.57M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Balchem's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude